Literature DB >> 24295642

Drug enterohepatic circulation and disposition: constituents of systems pharmacokinetics.

Yu Gao1, Jingwei Shao1, Zhou Jiang1, Jianzhong Chen2, Songen Gu1, Suhong Yu1, Ke Zheng3, Lee Jia4.   

Abstract

Drug disposition information constitutes a part of systems pharmacokinetics, and becomes imperative when a drug shows significant effects at its disproportionally low blood concentration. The situation could result from outweighing the parent drug in tissues over in blood and/or from its active metabolites. Fractions of certain drugs absorbed from the intestine to the systemic circulation via the portal vein can return to the intestine via the bile duct and the sphincter of Oddi - a complementary nonrenal elimination route termed the enterohepatic circulation (EHC). Here, we critically evaluate the existing methods, techniques and animal models used for determining drug distribution, elimination and EHC, and collectively portray characteristics of 43 drugs that undergo EHC. EHC could represent an unexplored way to excrete unwanted substrates out of the body. The interdisciplinary analysis galvanizes our efforts to overcome technical gaps in drug discovery and development.
Copyright © 2013 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Year:  2013        PMID: 24295642     DOI: 10.1016/j.drudis.2013.11.020

Source DB:  PubMed          Journal:  Drug Discov Today        ISSN: 1359-6446            Impact factor:   7.851


  10 in total

1.  Charactering the metabolism of cryptotanshinone by human P450 enzymes and uridine diphosphate glucuronosyltransferases in vitro.

Authors:  Jin Zeng; Yu-Juan Fan; Bo Tan; Hui-Zong Su; Yue Li; Lin-Lin Zhang; Jian Jiang; Fu-Rong Qiu
Journal:  Acta Pharmacol Sin       Date:  2018-02-08       Impact factor: 6.150

2.  Enterohepatic circulation of glucuronide metabolites of drugs in dog.

Authors:  Xin Zhou; Kenneth C Cassidy; Loyd Hudson; Michael A Mohutsky; Geri A Sawada; Junliang Hao
Journal:  Pharmacol Res Perspect       Date:  2019-07-04

3.  Enteric reabsorption processes and their impact on drug pharmacokinetics.

Authors:  Manuel Ibarra; Iñaki F Trocóniz; Pietro Fagiolino
Journal:  Sci Rep       Date:  2021-03-11       Impact factor: 4.379

4.  Predicting drug-metagenome interactions: Variation in the microbial β-glucuronidase level in the human gut metagenomes.

Authors:  Moamen M Elmassry; Sunghwan Kim; Ben Busby
Journal:  PLoS One       Date:  2021-01-07       Impact factor: 3.240

Review 5.  NSAID-Associated Small Intestinal Injury: An Overview From Animal Model Development to Pathogenesis, Treatment, and Prevention.

Authors:  Mingyu Zhang; Feng Xia; Suhong Xia; Wangdong Zhou; Yu Zhang; Xu Han; Kai Zhao; Lina Feng; Ruonan Dong; Dean Tian; Yan Yu; Jiazhi Liao
Journal:  Front Pharmacol       Date:  2022-02-09       Impact factor: 5.810

6.  Fixed Dose Single Tablet Formulation with Differential Release of Amlodipine Besylate and Simvastatin and Its Pharmacokinetic Profile: QbD and Risk Assessment Approach.

Authors:  Ummarah Kanwal; Shahid Mukhtar; Muzzamil Waheed; Arifa Mehreen; Nasir Abbas; Rahat Shamim; Khalid Hussain; Fatima Rasool; Amjad Hussain; Nadeem Irfan Bukhari
Journal:  Drug Des Devel Ther       Date:  2021-05-24       Impact factor: 4.162

7.  Sex-related pharmacokinetic differences and mechanisms of metapristone (RU486 metabolite).

Authors:  Wenge Chen; Yingying Xiao; Jianzhong Chen; Jian Liu; Jingwei Shao; Tao Li; Yewei Zhu; Ji Ma; Yu Gao; Jichuang Wang; Jianguo Xu; Yusheng Lu; Lee Jia
Journal:  Sci Rep       Date:  2017-12-07       Impact factor: 4.379

8.  Galeterone and The Next Generation Galeterone Analogs, VNPP414 and VNPP433-3β Exert Potent Therapeutic Effects in Castration-/Drug-Resistant Prostate Cancer Preclinical Models In Vitro and In Vivo.

Authors:  Andrew K Kwegyir-Afful; Senthilmurugan Ramalingam; Vidya P Ramamurthy; Puranik Purushottamachar; Francis N Murigi; Tadas S Vasaitis; Weiliang Huang; Maureen A Kane; Yuji Zhang; Nicholas Ambulos; Sudhir Tiwari; Pratima Srivastava; Ivo P Nnane; Arif Hussain; Yun Qiu; David J Weber; Vincent C O Njar
Journal:  Cancers (Basel)       Date:  2019-10-24       Impact factor: 6.639

9.  Eliminating blood oncogenic exosomes into the small intestine with aptamer-functionalized nanoparticles.

Authors:  Xiaodong Xie; Huifang Nie; Yu Zhou; Shu Lian; Hao Mei; Yusheng Lu; Haiyan Dong; Fengqiao Li; Tao Li; Bifei Li; Jie Wang; Min Lin; Chaihung Wang; Jingwei Shao; Yu Gao; Jianming Chen; Fangwei Xie; Lee Jia
Journal:  Nat Commun       Date:  2019-12-02       Impact factor: 14.919

Review 10.  Oleandrin: A Systematic Review of its Natural Sources, Structural Properties, Detection Methods, Pharmacokinetics and Toxicology.

Authors:  Jinxiao Zhai; Xiaoru Dong; Fenglian Yan; Hongsong Guo; Jinling Yang
Journal:  Front Pharmacol       Date:  2022-02-21       Impact factor: 5.810

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.